🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to examine the efficacy and safety of ...
Status
Completed
Location
49, CCR Ostrava, s.r.o
Start Date
2019-04-25
Trial ID
NCT03733314
This is a multicenter, Phase 1b, randomized, double-blind, placebo-controll...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT02249078
This study is a multicenter, randomized, double-blind, placebo-controlled, ...
Status
Completed
Location
Eisai Trial Site #1
Start Date
2016-10-20
Trial ID
NCT02960438
This study is a placebo-controlled, randomized, double-blind, multicenter, ...
Status
Terminated
Location
EA Pharma trial site
Start Date
2017-05-29
Trial ID
NCT03092765
This study consist of treatment phase (12 weeks) and extension phase (40 we...
Status
Completed
Location
Multiple Locations
Start Date
2014-05-26
Trial ID
NCT02196558
Treatments Being Tested
This study is a multicenter, randomized, double-blind, placebo-controlled, ...
Status
Completed
Location
Eisai Trial Site #1
Start Date
2016-11-26
Trial ID
NCT02960490
This study is a multicenter, open-label, uncontrolled, multiple ascending d...
Status
Completed
Location
Multiple Locations
Start Date
2014-04-05
Trial ID
NCT02039063
Treatments Being Tested
This study (Protocol No. E6011-J081-002) is a single-center, randomized, do...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT02146261
To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics...
Status
Completed
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT01731275
Treatments Being Tested